Skip to main content
. 2021 Nov 25;114(3):400–408. doi: 10.1093/jnci/djab213

Figure 2.

Figure 2.

Kaplan-Meier curves for disease-free survival according to treatment arm among (A) all randomly assigned patients, (B) patients with hormone receptor–positive breast cancer, and (C) patients with hormone receptor–negative breast cancer. All statistical tests were 2-sided. GnRHa = gonadotropin-releasing hormone agonist.